Request Demo
Last update 28 Jan 2026
Recombinant human growth factor-Fc fusion protein(Yifan Pharmaceutical Research Institute (Beijing) Co., Ltd.)
Last update 28 Jan 2026
Overview
Basic Info
Drug Type Fc fusion protein |
Synonyms F 899, F-899, F899 |
Target |
Action agonists |
Mechanism GHR agonists(Growth hormone receptor agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with Recombinant human growth factor-Fc fusion protein(Yifan Pharmaceutical Research Institute (Beijing) Co., Ltd.)CTR20211232
注射用重组人生长激素 -Fc融合蛋白(F-899)在健康受试者单次给药的安全性、耐受性及药代动力学/药效学研究
[Translation] Safety, tolerability and pharmacokinetic/pharmacodynamic study of a single dose of recombinant human growth hormone-Fc fusion protein for injection (F-899) in healthy subjects
100 Clinical Results associated with Recombinant human growth factor-Fc fusion protein(Yifan Pharmaceutical Research Institute (Beijing) Co., Ltd.)
Login to view more data
100 Translational Medicine associated with Recombinant human growth factor-Fc fusion protein(Yifan Pharmaceutical Research Institute (Beijing) Co., Ltd.)
Login to view more data
100 Patents (Medical) associated with Recombinant human growth factor-Fc fusion protein(Yifan Pharmaceutical Research Institute (Beijing) Co., Ltd.)
Login to view more data
100 Deals associated with Recombinant human growth factor-Fc fusion protein(Yifan Pharmaceutical Research Institute (Beijing) Co., Ltd.)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Growth hormone deficiency | Phase 1 | China | 13 Jul 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free